Green Cross Medical Science Corporation (KOSDAQ: 142280)
South Korea
· Delayed Price · Currency is KRW 3,935.00
-60.00 (-1.50%)
Oct 11, 2024, 9:00 AM KST
Green Cross Medical Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 96,291 | 94,011 | 113,109 | 101,675 | 113,377 | 81,493 | Upgrade
|
| Other Revenue | -0 | - | -0 | - | 0 | - | Upgrade
|
| Revenue | 96,291 | 94,011 | 113,109 | 101,675 | 113,377 | 81,493 | Upgrade
|
| Revenue Growth (YoY) | -2.63% | -16.88% | 11.25% | -10.32% | 39.13% | -5.59% | Upgrade
|
| Cost of Revenue | 82,909 | 80,056 | 100,363 | 100,043 | 93,601 | 72,208 | Upgrade
|
| Gross Profit | 13,382 | 13,955 | 12,746 | 1,631 | 19,777 | 9,285 | Upgrade
|
| Selling, General & Admin | 7,643 | 7,708 | 10,051 | 11,399 | 11,946 | 9,318 | Upgrade
|
| Research & Development | 3,050 | 2,880 | 2,167 | 2,134 | 2,654 | 2,188 | Upgrade
|
| Other Operating Expenses | 75.08 | 77.02 | 95.84 | 92.43 | 70.07 | 63.87 | Upgrade
|
| Operating Expenses | 13,012 | 12,683 | 14,554 | 21,795 | 15,578 | 12,301 | Upgrade
|
| Operating Income | 370.3 | 1,272 | -1,808 | -20,164 | 4,199 | -3,016 | Upgrade
|
| Interest Expense | -3,401 | -3,309 | -2,875 | -1,172 | -466.8 | -870.78 | Upgrade
|
| Interest & Investment Income | 207.49 | 273.96 | 394.85 | 26.27 | 46 | 32.6 | Upgrade
|
| Currency Exchange Gain (Loss) | -141.24 | -14.87 | 41.89 | 53.98 | -140.66 | 8.17 | Upgrade
|
| Other Non Operating Income (Expenses) | 4,708 | 4,050 | 641.81 | 89.11 | 3,439 | -5,684 | Upgrade
|
| EBT Excluding Unusual Items | 1,744 | 2,272 | -3,605 | -21,167 | 7,076 | -9,530 | Upgrade
|
| Gain (Loss) on Sale of Investments | -396.55 | -396.55 | 650.69 | 49.98 | 34.56 | 23.52 | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.35 | -9.99 | 3.55 | 8.38 | 127.23 | 2.48 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -1,988 | Upgrade
|
| Other Unusual Items | -190.09 | - | - | - | - | 120.81 | Upgrade
|
| Pretax Income | 1,159 | 1,865 | -2,951 | -21,108 | 7,238 | -11,372 | Upgrade
|
| Income Tax Expense | -11.03 | -11.34 | 108.07 | 29.84 | 210.74 | - | Upgrade
|
| Earnings From Continuing Operations | 1,170 | 1,877 | -3,059 | -21,138 | 7,027 | -11,372 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | 162.96 | -4,979 | Upgrade
|
| Net Income to Company | 1,170 | 1,877 | -3,059 | -21,138 | 7,190 | -16,350 | Upgrade
|
| Minority Interest in Earnings | 5.77 | -79.45 | -521.86 | -64.04 | -473.11 | 145.39 | Upgrade
|
| Net Income | 1,176 | 1,797 | -3,581 | -21,202 | 6,717 | -16,205 | Upgrade
|
| Net Income to Common | 1,176 | 1,797 | -3,581 | -21,202 | 6,717 | -16,205 | Upgrade
|
| Net Income Growth | -0.76% | - | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 27 | 21 | 21 | 21 | 11 | Upgrade
|
| Shares Change (YoY) | 20.38% | 26.96% | 0.05% | - | 90.86% | 16.07% | Upgrade
|
| EPS (Basic) | 55.69 | 85.25 | -169.87 | -1006.40 | 318.83 | -1468.10 | Upgrade
|
| EPS (Diluted) | 14.73 | 75.80 | -170.00 | -1006.40 | 318.83 | -1468.10 | Upgrade
|
| EPS Growth | -71.92% | - | - | - | - | - | Upgrade
|
| Free Cash Flow | -2,564 | -1,391 | 7,454 | -21,793 | -11,314 | -26,568 | Upgrade
|
| Free Cash Flow Per Share | -94.52 | -51.96 | 353.61 | -1034.47 | -537.04 | -2406.91 | Upgrade
|
| Gross Margin | 13.90% | 14.84% | 11.27% | 1.60% | 17.44% | 11.39% | Upgrade
|
| Operating Margin | 0.38% | 1.35% | -1.60% | -19.83% | 3.70% | -3.70% | Upgrade
|
| Profit Margin | 1.22% | 1.91% | -3.17% | -20.85% | 5.92% | -19.89% | Upgrade
|
| Free Cash Flow Margin | -2.66% | -1.48% | 6.59% | -21.43% | -9.98% | -32.60% | Upgrade
|
| EBITDA | 4,309 | 5,125 | 2,299 | -16,333 | 7,361 | -44.07 | Upgrade
|
| EBITDA Margin | 4.47% | 5.45% | 2.03% | -16.06% | 6.49% | -0.05% | Upgrade
|
| D&A For EBITDA | 3,938 | 3,854 | 4,107 | 3,831 | 3,162 | 2,972 | Upgrade
|
| EBIT | 370.3 | 1,272 | -1,808 | -20,164 | 4,199 | -3,016 | Upgrade
|
| EBIT Margin | 0.38% | 1.35% | -1.60% | -19.83% | 3.70% | -3.70% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 2.91% | - | Upgrade
|
| Advertising Expenses | - | 99.73 | 156.14 | 198.06 | 120.84 | 311.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.